Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AGLE

Aeglea BioTherapeutics

$8.73

-0.02 (-0.23%)

, ALTR

Altair

$41.00

0.49 (1.21%)

08:30
09/11/18
09/11
08:30
09/11/18
08:30
Options
Four new option listings and one option delisting on September 11th »

New option listings for…

AGLE

Aeglea BioTherapeutics

$8.73

-0.02 (-0.23%)

ALTR

Altair

$41.00

0.49 (1.21%)

SLDB

Solid Biosciences

$40.83

0.78 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 12

    Sep

  • 24

    Sep

  • 15

    Nov

  • 16

    Nov

AGLE

Aeglea BioTherapeutics

$9.35

-1.59 (-14.53%)

11:09
09/04/18
09/04
11:09
09/04/18
11:09
Downgrade
Aeglea BioTherapeutics rating change  »

Aeglea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

AGLE

Aeglea BioTherapeutics

$10.20

-0.74 (-6.76%)

10:49
09/04/18
09/04
10:49
09/04/18
10:49
Downgrade
Aeglea BioTherapeutics rating change at Wells Fargo »

Aeglea BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

AGLE

Aeglea BioTherapeutics

$10.94

0.05 (0.46%)

08:25
09/04/18
09/04
08:25
09/04/18
08:25
Conference/Events
Aeglea BioTherapeutics to hold a conference call »

Clinical data conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

AGLE

Aeglea BioTherapeutics

$10.94

0.05 (0.46%)

07:16
09/04/18
09/04
07:16
09/04/18
07:16
Hot Stocks
Aeglea BioTherapeutics announces data from pegzilarginase trial at SSIEM »

Aeglea BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

AGLE

Aeglea BioTherapeutics

$10.94

0.05 (0.46%)

04:55
09/04/18
09/04
04:55
09/04/18
04:55
Conference/Events
Aeglea BioTherapeutics to hold a conference call »

Clinical data conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

AGLE

Aeglea BioTherapeutics

$10.38

0.14 (1.37%)

15:24
08/27/18
08/27
15:24
08/27/18
15:24
Conference/Events
Aeglea BioTherapeutics to hold a conference call »

Clinical data conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Over a month ago
AGLE

Aeglea BioTherapeutics

$9.02

0.02 (0.22%)

08:10
08/09/18
08/09
08:10
08/09/18
08:10
Earnings
Aeglea BioTherapeutics reports Q2 EPS (46c), consensus (38c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGLE

Aeglea BioTherapeutics

$9.29

-0.06 (-0.64%)

16:01
07/19/18
07/19
16:01
07/19/18
16:01
Hot Stocks
Aeglea appoints Anthony Quinn president, CEO »

Aeglea BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
AGLE

Aeglea BioTherapeutics

$10.11

-0.01 (-0.10%)

07:09
06/14/18
06/14
07:09
06/14/18
07:09
Initiation
Aeglea BioTherapeutics initiated at BMO Capital »

Aeglea BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.